Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelsey Sokol

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|June 21, 2021
Treating Early-Stage DLBCL on the FLYER: What Lesson for Radiation Therapy?Kelsey Sokol, Amanda McBride, Adam Finn Binder, et al.
Chinese Clinical Oncology|March 2, 2019
Systemic therapy of cutaneous T-cell lymphoma (CTCL)Onder Alpdogan, Saritha Kartan, William Johnson, et al.
Leukemia & Lymphoma|February 23, 2021
Clinical characteristics and outcomes of black patients with mycosis fungoides and Sézary syndrome: a subgroup analysis of the phase III MAVORIC trialWilliam T Johnson, Saritha Kartan, Kelsey Sokol, et al.
Oncology (Williston Park, N.Y.)|May 31, 2018
Implications of Mutation Profiling in Myeloid Malignancies-PART 2: Myeloproliferative Neoplasms and Other Myeloid MalignanciesKelsey Sokol, Douglas Tremblay, Sheena Bhalla, et al.
Oncology (Williston Park, N.Y.)|April 24, 2018
Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid LeukemiaDouglas Tremblay, Kelsey Sokol, Sheena Bhalla, et al.
Chinese Clinical Oncology|January 30, 2019
The spectrum of CD30+ T cell lymphoproliferative disorders in the skinSaritha Kartan, William T Johnson, Kelsey Sokol, et al.
Frontiers in Oncology|July 3, 2019
Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL)Kelsey Sokol, Saritha Kartan, William T Johnson, et al.
Frontiers in Oncology|February 7, 2022
Implementation of an Outpatient HD-MTX InitiativeKelsey Sokol, Kelley Yuan, Maria Piddoubny, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|June 21, 2021
Treating Early-Stage DLBCL on the FLYER: What Lesson for Radiation Therapy?Kelsey Sokol, Amanda McBride, Adam Finn Binder, et al.
Chinese Clinical Oncology|March 2, 2019
Systemic therapy of cutaneous T-cell lymphoma (CTCL)Onder Alpdogan, Saritha Kartan, William Johnson, et al.
Leukemia & Lymphoma|February 23, 2021
Clinical characteristics and outcomes of black patients with mycosis fungoides and Sézary syndrome: a subgroup analysis of the phase III MAVORIC trialWilliam T Johnson, Saritha Kartan, Kelsey Sokol, et al.
Oncology (Williston Park, N.Y.)|May 31, 2018
Implications of Mutation Profiling in Myeloid Malignancies-PART 2: Myeloproliferative Neoplasms and Other Myeloid MalignanciesKelsey Sokol, Douglas Tremblay, Sheena Bhalla, et al.
Oncology (Williston Park, N.Y.)|April 24, 2018
Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid LeukemiaDouglas Tremblay, Kelsey Sokol, Sheena Bhalla, et al.
Chinese Clinical Oncology|January 30, 2019
The spectrum of CD30+ T cell lymphoproliferative disorders in the skinSaritha Kartan, William T Johnson, Kelsey Sokol, et al.
Frontiers in Oncology|July 3, 2019
Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL)Kelsey Sokol, Saritha Kartan, William T Johnson, et al.
Frontiers in Oncology|February 7, 2022
Implementation of an Outpatient HD-MTX InitiativeKelsey Sokol, Kelley Yuan, Maria Piddoubny, et al.
Pageof 1